MWNA
CDNA icon

Marshall Wace North America’s CareDx CDNA Stock Holding History

Marshall Wace North America’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,344
Closed -$215K – 1456
2021
Q2 		$215K Sell
2,344
-30,255
-93% -$2.4M ﹤0.01% 1338
2021
Q1 		$2.22M Buy
+32,599
New +$2.53M 0.01% 797
2020
Q4 		– Sell
-66,780
Closed -$2.53M – 1336
2020
Q3 		$2.53M Buy
66,780
+31,784
+91% +$1.07M 0.02% 528
2020
Q2 		$1.24M Buy
+34,996
New +$996K 0.01% 705
2020
Q1 		– Sell
-173,675
Closed -$3.75M – 1257
2019
Q4 		$3.75M Buy
+173,675
New +$3.98M 0.02% 443
2019
Q3 		– Sell
-48,237
Closed -$1.74M – 1329
2019
Q2 		$1.74M Buy
48,237
+36,322
+305% +$1.16M 0.01% 605
2019
Q1 		$376K Buy
+11,915
New +$347K ﹤0.01% 862
2018
Q3 		– Sell
-64,625
Closed -$791K – 965
2018
Q2 		$791K Buy
64,625
+47,266
+272% +$542K ﹤0.01% 995
2018
Q1 		$138K Buy
+17,359
New +$107K ﹤0.01% 1358

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Marshall Wace North America's CDNA Position: Q3 2021 in Review

Marshall Wace North America sold out of CareDx (CDNA) in Q3 2021, closing a stake of 2,344 shares — an estimated $215K sold.

Marshall Wace North America first reported a position in CDNA in Q1 2018 and held it in 9 quarters. The position peaked at $3.75M in Q4 2019. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.

  • Marshall Wace North America reported no remaining CareDx position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 2,344 CareDx shares in Q3 2021, an estimated $215K.
  • Marshall Wace North America first reported a position in CareDx in Q1 2018 and held it in 9 quarters.
  • Marshall Wace North America's CareDx position peaked at $3.75M in Q4 2019.
  • 260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.